MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier

Background: Molecular analysis of indeterminate thyroid nodules has been shown to reduce unnecessary surgeries for benign thyroid nodules. Afirma Gene Expression Classifier (GEC) has a reported benign call rate (BCR) of 38-61%, and the newer generation Genomic Sequencing Classifier (GSC) has a repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Polavarapu, Preethi, Fingeret, Abbey, Yuil-Valdes, Ana, Patel, Anery, Goldner, Whitney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208169/
http://dx.doi.org/10.1210/jendso/bvaa046.1141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208169/
http://dx.doi.org/10.1210/jendso/bvaa046.1141

Ejemplares similares